Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 47.4% – Still a Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares traded up 47.4% on Saturday . The stock traded as high as C$0.14 and last traded at C$0.14. 1,312,210 shares were traded during trading, an increase of 427% from the average session volume of 249,010 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Stock Up 47.4 %

The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock’s fifty day simple moving average is C$0.08 and its 200-day simple moving average is C$0.06. The stock has a market cap of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

See Also

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.